Analyst Price Target is $24.75
▲ +7.61% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for Prevail Therapeutics in the last 3 months. The average price target is $24.75, with a high forecast of $26.00 and a low forecast of $23.00. The average price target represents a 7.61% upside from the last price of $23.00.
Current Consensus is
The current consensus among 8 contributing investment analysts is to hold stock in Prevail Therapeutics. This rating has held steady since June 2020, when it changed from a Buy consensus rating.